Thinking about buying into biotech ahead of the JPMorgan Health Care Conference? History says the best play is to buy the day before the meeting starts and hold until the end.
The JPMorgan conference, from Monday to Thursday, is the health industry's biggest annual event, setting the agenda for the year. Sentiment out of the conference can dominate the first half of the year.
"It may be the most important health-care conference in investment banking," said Les Funtleyder, portfolio manager at E-Squared Asset Management and author of "Health-Care Investing."
More than 400 companies present to thousands of conference attendees—not to mention the thousands more who flock to San Francisco for ancillary meetings.
Because biotech is notoriously volatile, we asked Kensho, a quantitative analysis investing tool, how history suggests playing it.
Here's what it told us, looking at 18 years of the conference:
So how bout them apples? See you in San Francisco.
Disclosure: NBCUniversal, parent of CNBC, is a minority investor in Kensho.